Literature DB >> 1444215

Growth effects of tamoxifen on Lovo colon carcinoma cells and cultured cells from normal colonic mucosa.

P Lointier1, D M Wildrick, B M Boman.   

Abstract

The growth effects of tamoxifen (TAM) were studied using normal and malignant colonic epithelial cells. Addition of TAM (0.8 to 10 microM) to cultured normal human colon epithelial cells and Lovo colon adenocarcinoma cells produced a dose response decrease in growth of 42 to 76%. Histamine (1 to 10 microM) did not affect cell growth and did not negate the TAM effect. Calmodulin (2 micrograms/ml) totally blocked growth inhibitory effects of a calmodulin antagonist, trifluoperazine (10 microM), but did not block the TAM inhibitory effect. These data suggest that antiestrogen binding sites (AEBS) may play an important role in the growth-inhibitory effects of TAM on colon cells. Competition with estrogen and antagonism with histamine or calmodulin do not appear to be significant in this regard.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444215

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Isolation of normal human colonic mucosa: comparison of methods.

Authors:  D M Wildrick; P Lointier; D H Nichols; R Roll; B Quintanilla; B M Boman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-01       Impact factor: 2.416

Review 2.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

3.  Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.

Authors:  Samy A F Morad; James P Madigan; Jonathan C Levin; Noha Abdelmageed; Ramin Karimi; Daniel W Rosenberg; Mark Kester; Sriram S Shanmugavelandy; Myles C Cabot
Journal:  Biochem Pharmacol       Date:  2013-01-24       Impact factor: 5.858

4.  "Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.

Authors:  Xueying Sun; Ruohan Jiang; Aneta Przepiorski; Shiva Reddy; Kate P Palmano; Geoffrey W Krissansen
Journal:  BMC Cancer       Date:  2012-12-11       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.